Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMMED S BUKARI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1487802385
CMS profile
832586
Location
CLOVIS, CA

General Payments · PY2018–2024

$25,943.51

  • Reported across 263 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,966.99

59 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,700.00 1
Food and Beverage $1,181.94 57
Education $85.05 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $372.44 13
PY2019 $3,469.48 93
PY2020 $358.99 13
PY2021 $1,617.45 5
PY2022 $12,347.62 24
PY2023 $3,810.54 56
PY2024 $3,966.99 59

Payment records · PY2024 (59)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Apellis Pharmaceuticals, Inc. $27.81 04/24/2024 Food and Beverage Undisputed 01/23/2026 1154026704 CMS
ARRAY BIOPHARMA INC $0.72 11/08/2024 Food and Beverage Undisputed 01/23/2026 1131157481 CMS
ARRAY BIOPHARMA INC $12.12 11/12/2024 Food and Beverage Undisputed 01/23/2026 1131271220 CMS
Astellas Pharma US Inc $85.05 01/12/2024 Education Undisputed 01/23/2026 1139385282 CMS
Astellas Pharma US Inc $16.71 04/18/2024 Food and Beverage Undisputed 01/23/2026 1139325968 CMS
Astellas Pharma US Inc $17.65 05/09/2024 Food and Beverage Undisputed 01/23/2026 1139334910 CMS
Astellas Pharma US Inc $16.59 10/24/2024 Food and Beverage Undisputed 01/23/2026 1139424787 CMS
bluebird bio, Inc. $20.01 06/04/2024 Food and Beverage Undisputed 01/23/2026 1095479543 CMS
Celgene Corporation $15.76 04/09/2024 Food and Beverage Undisputed 01/23/2026 1101158856 CMS
Celgene Corporation $24.63 10/22/2024 Food and Beverage Undisputed 01/23/2026 1101158872 CMS
Celgene Corporation $25.08 10/25/2024 Food and Beverage Undisputed 01/23/2026 1101158874 CMS
Celgene Corporation $21.53 12/04/2024 Food and Beverage Undisputed 01/23/2026 1101158878 CMS
Daiichi Sankyo Inc. $10.02 01/04/2024 Food and Beverage Undisputed 01/23/2026 1089404240 CMS
Daiichi Sankyo Inc. $17.92 01/17/2024 Food and Beverage Undisputed 01/23/2026 1089404242 CMS
Daiichi Sankyo Inc. $14.06 02/07/2024 Food and Beverage Undisputed 01/23/2026 1089404244 CMS
Daiichi Sankyo Inc. $6.54 02/13/2024 Food and Beverage Undisputed 01/23/2026 1089404246 CMS
Daiichi Sankyo Inc. $27.67 03/15/2024 Food and Beverage Undisputed 01/23/2026 1089404236 CMS
Daiichi Sankyo Inc. $8.22 04/11/2024 Food and Beverage Undisputed 01/23/2026 1089404238 CMS
Daiichi Sankyo Inc. $24.60 07/11/2024 Food and Beverage Undisputed 01/23/2026 1089404248 CMS
Daiichi Sankyo Inc. $4.94 08/28/2024 Food and Beverage Undisputed 01/23/2026 1089404250 CMS
Daiichi Sankyo Inc. $16.92 09/19/2024 Food and Beverage Undisputed 01/23/2026 1089404252 CMS
Deciphera Pharmaceuticals Inc. $14.59 07/18/2024 Food and Beverage Undisputed 01/23/2026 1145872407 CMS
E.R. Squibb & Sons, L.L.C. $16.39 02/09/2024 Food and Beverage Undisputed 01/23/2026 1101582839 CMS
E.R. Squibb & Sons, L.L.C. $14.24 03/14/2024 Food and Beverage Undisputed 01/23/2026 1101582831 CMS
E.R. Squibb & Sons, L.L.C. $22.32 05/23/2024 Food and Beverage Undisputed 01/23/2026 1101582917 CMS
E.R. Squibb & Sons, L.L.C. $20.02 11/14/2024 Food and Beverage Undisputed 01/23/2026 1101582982 CMS
Exelixis Inc. $34.45 02/09/2024 Food and Beverage Undisputed 01/23/2026 1138562408 CMS
Genentech USA, Inc. $25.56 09/06/2024 Food and Beverage Undisputed 01/23/2026 1133075128 CMS
GlaxoSmithKline, LLC. $15.86 06/20/2024 Food and Beverage Undisputed 01/23/2026 1116402453 CMS
GlaxoSmithKline, LLC. $14.31 12/17/2024 Food and Beverage Undisputed 01/23/2026 1116149333 CMS
Incyte Corporation $16.23 05/23/2024 Food and Beverage Undisputed 01/23/2026 1141295578 CMS
Janssen Biotech, Inc. $19.91 05/31/2024 Food and Beverage Undisputed 01/23/2026 1078291778 CMS
Janssen Biotech, Inc. $32.22 06/06/2024 Food and Beverage Undisputed 01/23/2026 1078291805 CMS
Janssen Biotech, Inc. $14.60 08/23/2024 Food and Beverage Undisputed 01/23/2026 1078291531 CMS
Janssen Biotech, Inc. $18.94 09/11/2024 Food and Beverage Undisputed 01/23/2026 1078291447 CMS
Merck Sharp & Dohme LLC $29.79 03/07/2024 Food and Beverage Undisputed 01/23/2026 1141877485 CMS
Novartis Pharmaceuticals Corporation $6.67 01/12/2024 Food and Beverage Undisputed 01/23/2026 1086730509 CMS
Novartis Pharmaceuticals Corporation $22.73 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086730503 CMS
Novartis Pharmaceuticals Corporation $28.55 03/28/2024 Food and Beverage Undisputed 01/23/2026 1086730507 CMS
Novartis Pharmaceuticals Corporation $2,700.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 1086730511 CMS
Novartis Pharmaceuticals Corporation $28.04 07/16/2024 Food and Beverage Undisputed 01/23/2026 1086730521 CMS
Novartis Pharmaceuticals Corporation $21.52 09/03/2024 Food and Beverage Undisputed 01/23/2026 1086730523 CMS
Novartis Pharmaceuticals Corporation $7.95 10/16/2024 Food and Beverage Undisputed 01/23/2026 1086730525 CMS
Novartis Pharmaceuticals Corporation $5.78 10/21/2024 Food and Beverage Undisputed 01/23/2026 1086730529 CMS
Novartis Pharmaceuticals Corporation $0.71 10/21/2024 Food and Beverage Undisputed 01/23/2026 1086730531 CMS
Novartis Pharmaceuticals Corporation $27.12 11/08/2024 Food and Beverage Undisputed 01/23/2026 1086730527 CMS
Novartis Pharmaceuticals Corporation $9.84 12/12/2024 Food and Beverage Undisputed 01/23/2026 1086730535 CMS
PFIZER INC. $36.27 03/11/2024 Food and Beverage Undisputed 01/23/2026 1131717672 CMS
PFIZER INC. $26.34 05/04/2024 Food and Beverage Undisputed 01/23/2026 1131723384 CMS
PFIZER INC. $31.40 05/16/2024 Food and Beverage Undisputed 01/23/2026 1131714716 CMS
PFIZER INC. $15.73 08/08/2024 Food and Beverage Undisputed 01/23/2026 1131859445 CMS
PFIZER INC. $21.02 10/15/2024 Food and Beverage Undisputed 01/23/2026 1131372455 CMS
PFIZER INC. $126.57 11/21/2024 Food and Beverage Undisputed 01/23/2026 1130879672 CMS
SERVIER PHARMACEUTICALS LLC $24.92 10/17/2024 Food and Beverage Undisputed 01/23/2026 1147262132 CMS
SERVIER PHARMACEUTICALS LLC $24.72 11/22/2024 Food and Beverage Undisputed 01/23/2026 1147262134 CMS
SERVIER PHARMACEUTICALS LLC $20.91 12/11/2024 Food and Beverage Undisputed 01/23/2026 1147262136 CMS
SERVIER PHARMACEUTICALS LLC $15.26 12/17/2024 Food and Beverage Undisputed 01/23/2026 1147262138 CMS
TAIHO ONCOLOGY, INC. $25.50 06/20/2024 Food and Beverage Undisputed 01/23/2026 1137934933 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.46 01/26/2024 Food and Beverage Undisputed 01/23/2026 1144954383 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.